- Home
- FTI vs SNN Comparison
FTI vs SNN Comparison
Compare FTI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTI
- SNN
- Stock Information
- Founded
- FTI 1884
- SNN 1856
- Country
- FTI United States
- SNN United Kingdom
- Employees
- FTI N/A
- SNN N/A
- Industry
- FTI Metal Fabrications
- SNN Industrial Specialties
- Sector
- FTI Industrials
- SNN Health Care
- Exchange
- FTI Nasdaq
- SNN Nasdaq
- Market Cap
- FTI 16.6B
- SNN 15.2B
- IPO Year
- FTI N/A
- SNN 1999
- Fundamental
- Price
- FTI $43.75
- SNN $33.34
- Analyst Decision
- FTI Strong Buy
- SNN Hold
- Analyst Count
- FTI 11
- SNN 4
- Target Price
- FTI $45.60
- SNN $33.50
- AVG Volume (30 Days)
- FTI 4.3M
- SNN 664.9K
- Earning Date
- FTI 10-23-2025
- SNN 10-30-2025
- Dividend Yield
- FTI 0.46%
- SNN 2.19%
- EPS Growth
- FTI 59.09
- SNN 59.91
- EPS
- FTI 2.28
- SNN 0.56
- Revenue
- FTI $9,803,000,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- FTI $10.39
- SNN $7.85
- Revenue Next Year
- FTI $7.41
- SNN $5.43
- P/E Ratio
- FTI $19.18
- SNN $59.75
- Revenue Growth
- FTI 11.44
- SNN 5.35
- 52 Week Low
- FTI $22.12
- SNN $23.69
- 52 Week High
- FTI $43.90
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- FTI 71.14
- SNN 34.58
- Support Level
- FTI $41.73
- SNN $31.83
- Resistance Level
- FTI $43.09
- SNN $33.60
- Average True Range (ATR)
- FTI 1.39
- SNN 0.54
- MACD
- FTI 0.37
- SNN -0.37
- Stochastic Oscillator
- FTI 96.89
- SNN 26.67
About FTI TechnipFMC plc
TechnipFMC is the largest provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.